Fortrea Holdings Inc. FTRE Clinical Services Segment — D&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Fortrea Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The official record: Fortrea Holdings Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fortrea Holdings Inc.'s clinical services segment — d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Fortrea Holdings Inc.'s clinical services segment — D&A?
- Fortrea Holdings Inc. (FTRE) reported clinical services segment — D&A of $5.2M in Q1 2026.
- How has Fortrea Holdings Inc.'s clinical services segment — D&A changed year-over-year?
- Fortrea Holdings Inc.'s clinical services segment — D&A increased by 4.0% year-over-year, from $5M to $5.2M.
- What is the long-term trend for Fortrea Holdings Inc.'s clinical services segment — D&A?
- Over 3 years (2022 to 2025), Fortrea Holdings Inc.'s clinical services segment — D&A has grown at a -5.0% compound annual growth rate (CAGR), from $23M to $19.7M.
- What does clinical services segment — D&A mean?
- Represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within the clinical services segment. This non-cash expense reflects the capital intensity of the segment's infrastructure and equipment requirements.